Perrigo Ordinary Shares reported $4.11B in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Bayer BAYN:GR EUR 44.79B 157M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Catalent CTLT:US USD 4.2B 2M
Coherus Biosciences CHRS:US USD 245.25M 175.72M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
Horizon Pharma HZNP:US USD 2.57B 1.85M
Lannett LCI:US USD 623.86M 4.51M
Nestle NESN:VX 54.03B 7.45B
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Perrigo Ordinary Shares PRGO:US USD 4.11B 5.9M
Phibro Animal Health PAHC:US USD 467.16M 34.23M
Prestige Brands PBH:US USD 1.43B 14.93M
Reckitt Benckiser Group PLC RB/:LN GBP 9.73B 166M
Supernus Pharmaceuticals SUPN:US USD 401.44M 529K
Teva Pharmaceutical TEVA:IT USD 21.27B 816M
Xeris Pharmaceuticals Inc XERS:US USD 138.51M 439K
Zoetis ZTS:US USD 6.56B 10M